Why no public email yet?
Level Trailhead 49 maintains careful editorial controls and will publish a contact channel when it can be staffed to handle inquiries responsibly; in the meantime, the About page describes sourcing and corrections policy.
Contact
An independent resource on ibogaine evidence, risk, and regulation.
Level Trailhead 49 welcomes corrections, questions, or feedback on the site's content and presentation. If you have updates or concerns about our materials, please check the site's editorial information on the About page for details on sourcing and policy before reaching out.
How to reach us
There is currently no public email or contact form published. The site can be reached through its published channels; please check back for contact details as they become available.
If you prefer to explore the broader site while you wait, our homepage summarizes recent updates and navigation at the Level Trailhead 49 homepage.
Corrections & feedback
For factual corrections or to suggest sources, consult our editorial approach on the About page and return here to see published contact channels when available.
A note on scope
Trellis Ember organizes accessible, evidence-first information on ibogaine, noribogaine, and related research. We foreground efficacy signals alongside cardiac-safety questions. This page focuses on contact only; please see About for editorial context.
Interactive modules
Can I propose a correction?
Yes. When contact channels are displayed they will include guidance on the preferred format for corrections and evidence submissions. Meanwhile, please consult our editorial practices on the About page.